Pacer Advisors Inc. Acquires 224,865 Shares of Jazz Pharmaceuticals plc - MarketBeat
J7Z Stock | EUR 114.95 1.55 1.33% |
Roughly 62% of Jazz Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Jazz Pharmaceuticals plc suggests that many traders are alarmed regarding Jazz Pharmaceuticals' prospects. The current market sentiment, together with Jazz Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Jazz Pharmaceuticals plc stock news signals to limit their universe of possible portfolio assets.
Jazz Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Jazz daily returns and investor perception about the current price of Jazz Pharmaceuticals plc as well as its diversification or hedging effects on your existing portfolios.
Jazz |
Pacer Advisors Inc. Acquires 224,865 Shares of Jazz Pharmaceuticals plc MarketBeat
Read at news.google.com
Jazz Pharmaceuticals Fundamental Analysis
We analyze Jazz Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jazz Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jazz Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Jazz Pharmaceuticals is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Jazz Pharmaceuticals plc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jazz Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Jazz Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Jazz Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Jazz Pharmaceuticals Related Equities
0VF | Virtu Financial | 3.49 | ||||
0UI | United Insurance | 1.74 | ||||
A4A | ANGLO ASIAN | 1.64 | ||||
SYU1 | Synovus Financial | 1.41 | ||||
JATA | JAPAN TOBACCO | 0.85 | ||||
LIE | Sun Life | 0.88 | ||||
8ZI | Scandinavian Tobacco | 1.68 |
Complementary Tools for Jazz Stock analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
CEOs Directory Screen CEOs from public companies around the world | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |